Oxcarbazepine

Preview FDA label, Zydus Pharmaceuticals (USA) Inc., oral, effective 2026-06-13. Full label on DailyMed

Quoted from the FDA label. Product labels differ by manufacturer and change over time; confirm against the label for the product you are using. Not yet reviewed by a ClinDose pharmacist.

Dosing in kidney impairment

Dosage Modification for Patients with Renal Impairment In patients with impaired renal function (creatinine clearance <30 mL/min), initiate oxcarbazepine tablets at one-half the usual starting dose (300 mg/day, given twice a day), and increase slowly to achieve the desired clinical response [ see Clinical Pharmacology ]

Preparation and administration

Administration Information Oxcarbazepine tablets can be taken with or without food [ see Clinical Pharmacology ]. Oxcarbazepine oral suspension and oxcarbazepine tablets may be substituted at equal doses.